CCB International To Set Up First Health Care Industry Fund With RMB 5 Billion
This article was originally published in PharmAsia News
CCB International, a wholly-owned subsidiary of China Construction Bank Corporation, recently revealed that it has been establishing a health care investment fund since November 2007. With a first phase investment not exceeding RMB 5 billion, the Tianjin-registered fund will be China's first private equity focusing on the health care industry, including pharmaceuticals, medical devices, medical institutions and health care services. The seven-year closed-end fund obtains capital from various undisclosed sources. CCB International will collaborate with well-known domestic and overseas health care management funds and groups to jointly manage the fund. According to survey, China has a total of 5,744 health care management organizations covering 23 provinces, four municipalities and four autonomous regions. (Click here for more - Chinese Language)
You may also be interested in...
Abbott reported third-quarter 2020 global sales of $8.9bn, driven by its strong position in COVID-19 tests. See what Abbott’s CEO Robert Ford said about it here.
With the threat of potentially hefty fines, China's newly passed Biosecurity Law will fundamentally change how the life science sector handles human genetic resources over years to come, legal experts say.
Ahead of the vaccine advisory committee, requests to FDA range from public health groups opposing emergency use authorizations to industry seeking labeling guidance on EUA products.